Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-22

FDA Approved: MIRTAZAPINE — Supplemental Application (Aurolife Pharma LLC)

View source ↗

Summary

The FDA approved a supplemental application for mirtazapine from Aurolife Pharma LLC, enabling the marketed generic to proceed under an approved supplemental in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • mirtazapine (mirtazapine)

Snippet

SUPPL AP for MIRTAZAPINE (MIRTAZAPINE)